
University of Nebraska-Lincoln researchers developed an H5N1 vaccine platform combining intramuscular and intranasal delivery, which protected mice and dairy calves in preclinical tests. The findings are forthcoming in NPJ Vaccines, and no H5N1 vaccine for cattle is currently licensed.
A viable cattle vaccine could eventually reduce dairy herd losses and milk output disruption, but it is preclinical and has no near-term effect on feed demand or prices.
After 22 past neutral disease events, Milk (Class III) moved a median -0.1% over 5 sessions (41% higher; middle half -1.4% to +0.5%), and +0.2% over 20.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.